Zurich Cantonal Bank
ABMD

Zurich Cantonal Bank’s Abiomed Inc ABMD Stock Holding History

Zurich Cantonal Bank’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-8,499
Closed -$2.09M – 2948
2022
Q3 		$2.09M Sell
8,499
-1,574
-16% -$425K 0.01% 656
2022
Q2 		$2.49M Buy
10,073
+221
+2% +$59.6K 0.01% 632
2022
Q1 		$3.26M Buy
9,852
+1,647
+20% +$507K 0.02% 615
2021
Q4 		$2.95M Sell
8,205
-4,367
-35% -$1.48M 0.01% 652
2021
Q3 		$4.09M Sell
12,572
-190
-1% -$64.4K 0.02% 565
2021
Q2 		$3.98M Sell
12,762
-1,753
-12% -$538K 0.02% 546
2021
Q1 		$4.63M Sell
14,515
-7,860
-35% -$2.52M 0.03% 507
2020
Q4 		$7.25M Buy
22,375
+11,023
+97% +$3.05M 0.04% 390
2020
Q3 		$3.15M Buy
11,352
+2,610
+30% +$752K 0.02% 570
2020
Q2 		$2.11M Sell
8,742
-3,787
-30% -$760K 0.02% 624
2020
Q1 		$1.82M Buy
12,529
+3,631
+41% +$603K 0.02% 629
2019
Q4 		$1.52M Hold
8,898
– – 0.01% 737
2019
Q3 		$1.58M Buy
8,898
+383
+4% +$82.8K 0.01% 712
2019
Q2 		$2.22M Hold
8,515
– – 0.02% 623
2019
Q1 		$2.43M Hold
8,515
– – 0.02% 579
2018
Q4 		$2.77M Sell
8,515
-386
-4% -$134K 0.03% 522
2018
Q3 		$4M Sell
8,901
-158
-2% -$62.3K 0.03% 478
2018
Q2 		$3.71M Buy
9,059
+6,644
+275% +$2.41M 0.03% 495
2018
Q1 		$703K Hold
2,415
– – 0.01% 820
2017
Q4 		$453K Buy
2,415
+904
+60% +$169K ﹤0.01% 886
2017
Q3 		$255K Hold
1,511
– – ﹤0.01% 961
2017
Q2 		$217K Buy
1,511
+197
+15% +$26.5K ﹤0.01% 970
2017
Q1 		$165K Hold
1,314
– – ﹤0.01% 1071
2016
Q4 		$148K Hold
1,314
– – ﹤0.01% 1087
2016
Q3 		$169K Buy
1,314
+155
+13% +$18.6K ﹤0.01% 988
2016
Q2 		$127K Hold
1,159
– – ﹤0.01% 1039
2016
Q1 		$110K Hold
1,159
– – ﹤0.01% 1080
2015
Q4 		$105K Buy
1,159
+653
+129% +$55.4K ﹤0.01% 1117
2015
Q3 		$47K Buy
506
+363
+254% +$32K ﹤0.01% 1127
2015
Q2 		$9K Hold
143
– – ﹤0.01% 1475
2015
Q1 		$10K Buy
+143
New +$7.76K ﹤0.01% 1386
2014
Q3 		– Sell
-40,000
Closed -$1.01M – 997
2014
Q2 		$1.01M Hold
40,000
– – 0.03% 558
2014
Q1 		$1.04M Buy
+40,000
New +$1.11M 0.03% 516
2013
Q4 		– Sell
-60,000
Closed -$1.14M – 995
2013
Q3 		$1.14M Buy
60,000
+50,000
+500% +$1.14M 0.04% 429
2013
Q2 		$216K Buy
+10,000
New +$201K 0.01% 794

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Zurich Cantonal Bank's ABMD Position: Q4 2022 in Review

Zurich Cantonal Bank sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 8,499 shares — an estimated $2.09M sold.

Zurich Cantonal Bank first reported a position in ABMD in Q2 2013 and held it in 35 quarters. The position peaked at $7.25M in Q4 2020. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Zurich Cantonal Bank reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Zurich Cantonal Bank sold 8,499 Abiomed Inc shares in Q4 2022, an estimated $2.09M.
  • Zurich Cantonal Bank first reported a position in Abiomed Inc in Q2 2013 and held it in 35 quarters.
  • Zurich Cantonal Bank's Abiomed Inc position peaked at $7.25M in Q4 2020.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Zurich Cantonal Bank's 13F filing for Q4 2022, filed 1 Feb 2023.